Skip to main content

Table 2 Details of the responses to the questionnaire with number and percentage in agreement with the question

From: Experimental system of care coordination for the home return of patients with metastatic cancer: a survey of general practitioners

 

N (%)

Responded to the survey in general (n = 100)

 

Concerning the phone call (n = 100)

 Remembered receiving a call to exchange information on the patient’s state of health and his/her wishes for treatment

40 (40.0)

 The timing of the call was appropriate

36 (94.7)

 The duration of the call was appropriate

40 (100)

 The use of the telephone for this exchange of information seemed appropriate

36 (90.0)

 The exchange of information was facilitated by the fact that the caller was a physician

36 (92.3)

Concerning the link sheet (n = 100)

 Remembered receiving a link sheet summarizing information on the patient’s health status and his or her wishes for care

51 (51.0)

 Considered the link sheet useful

39 (76.5)

Concerning CREDO exchanges in general (n = 33 to 85)

Satisfaction (“satisfied” or “rather satisfied”) with CREDO exchanges (n = 58)

49 (84.5)

The exchanges, during the telephone call and via the link form, provided information concerning the patient (n = 75)

38 (50.7)

Classification of information areas where CREDO exchanges have brought new data (n = 38) a

  Possible or expected side effects of specific treatments

25 (65.8)

  Future specific therapeutic management (chemotherapy, radiotherapy)

20 (52.6)

  Treatments maintained after hospital discharge

19 (50.0)

  Possible or expected complications

19 (50.0)

  What to do if complications and/or adverse effects occur

19 (50.0)

  General state at discharge (WHO score)

16 (42.1)

  Precise carcinological situation (type of cancer, location of metastases)

16 (42.1)

  Patient’s wishes regarding the place of care in case of complications

15 (39.5)

  Dates of the next scheduled consultations and/or hospitalizations

12 (31.6)

  Reason for current hospitalization

9 (23.7)

  Concomitant pathologies

6 (15.8)

  1. a multiple choice question